Revenio Group Oyj (REG1V) Earnings Call Transcripts

25 earnings calls from February 2020 to September 8, 2026

HLSE FI Health Care Health Care Equipment and Supplies

Revenio Group Oyj's Latest Earnings Call - April 13, 2026

In the first quarter of fiscal year 2026, Visionix Ltd. announced a significant acquisition of Visionix, which is expected to enhance its product portfolio and expand its market reach from EUR 1 billion to EUR 2.5 billion. The deal is valued at EUR 290 million, with expected synergies of EUR 20 million by the end of 2027. Management indicated that the combined company would target a 25% EBITDA margin by 2028-2029, reflecting a strong commitment to growth and profitability improvements.

Reported metrics

MetricValueContext
Acquisition Value EUR 290 million (positive) Valuation for the acquisition of Visionix, enhancing market position.
Market Size Increase EUR 2.5 billion (positive) Accessible market expected to grow from EUR 1 billion to EUR 2.5 billion post-acquisition.
Synergies Target EUR 20 million (positive) Targeted synergies from the acquisition, with 70% expected by end of 2027.
EBITDA Margin Target 25% (positive) Target EBITDA margin by 2028-2029, indicating profitability goals.
Debt Financing EUR 130 million (neutral) Term loan facility secured for the acquisition financing.
Sales Growth Rate 3x faster than market (positive) Management's ambition for growth post-acquisition.

Guidance from management

Management withdrew previous guidance and will provide new guidance after the completion of the Visionix acquisition, targeting a 25% EBITDA margin by 2028-2029.

What management said

Thank you, Arne. And perhaps the continuation question, which goes for Charles. So it has been clear since beginning when talking with Marc when talking with you, Charles, that you are not just selling, say, Visionix shareholder the shares out, but you are committed to the longer-term journey. So can you a bit explain that logic for us? Also, I think you are going to subscribe the shares with the higher price where ...
— Jouni Toijala, April 13, 2026 earnings call
Thank you. Thank you, Charles. And perhaps giving another shareholder spin on this one. So Arne, are you a bit able to open the logic? So William Demant, our biggest shareholder, almost owning roughly 25% of the shares is also committed in a long run. So from the all shareholders' perspective, are you able to open that one a bit?
— Jouni Toijala, April 13, 2026 earnings call

What analysts pressed on

Analysts expressed concerns regarding the historical growth trajectory of Visionix, particularly its flat performance in recent years. Questions were raised about integration challenges and the potential impact of overlapping products on sales.

Main topics on the call

Read the full Revenio Group Oyj transcript (April 13, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Revenio Group Oyj

Revenio Group Oyj (REG1V) is a publicly listed company in the Health Care Equipment and Supplies industry, within the Health Care sector. It trades on HLSE and is based in FI. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 25 calls on record spanning February 20, 2020 to September 8, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 25 Revenio Group Oyj earnings call transcripts on record, spanning February 20, 2020 to September 8, 2026. Based on this history, Revenio Group Oyj reports quarterly. The most recent call on file is dated September 8, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
REG1V
Exchange
HLSE
Country
FI
Sector
Health Care
Industry
Health Care Equipment and Supplies
Calls on record
25
First call
February 20, 2020
Most recent
September 8, 2026
Reporting cadence
quarterly
Quarter Date
Q2 FY2026 Sep 8, 2026 Read transcript
Q1 FY2026 Apr 28, 2026 Read transcript
M&A Calls Apr 13, 2026 Read transcript
Earnings Calls Feb 11, 2026 Read transcript
Earnings Calls Oct 30, 2025 Read transcript
Earnings Calls Aug 7, 2025 Read transcript
Q1 FY2025 Apr 29, 2025 Read transcript
Earnings Calls Feb 13, 2025 Read transcript
Earnings Calls Oct 31, 2024 Read transcript
Q2 FY2024 Aug 8, 2024 Read transcript
Q1 FY2024 Apr 25, 2024 Read transcript
Earnings Calls Feb 15, 2024 Read transcript
Analyst/Investor Day Nov 30, 2023 Read transcript
Q3 FY2023 Oct 26, 2023 Read transcript
Earnings Calls Aug 10, 2023 Read transcript
Q1 FY2023 Apr 27, 2023 Read transcript
Earnings Calls Feb 9, 2023 Read transcript
Earnings Calls Oct 27, 2022 Read transcript
Q2 FY2022 Aug 4, 2022 Read transcript
Q1 FY2022 Apr 28, 2022 Read transcript
Earnings Calls Feb 10, 2022 Read transcript
Q3 FY2021 Oct 21, 2021 Read transcript
Earnings Calls Aug 5, 2021 Read transcript
Earnings Calls Feb 11, 2021 Read transcript
Earnings Calls Feb 20, 2020 Read transcript